Dr Reddy's and Takeda to Launch Dengue Vaccine QDENGA in India in 2027
Audio narration · Coming soon
Dr Reddy's Laboratories and Takeda Pharmaceutical Company have formed an exclusive partnership to promote and distribute Takeda's dengue vaccine, QDENGA, in India's private market starting in 2027. This collaboration aims to enhance dengue prevention efforts in India through private sector availability.
Why this matters
PRISM scored this story 55/100 for interest.
Originally published by gnews